This ninth annual meeting represents the premier management and investment conference for the new and emerging bioelectronic medicine industry. Attendees will have an exclusive opportunity to interact with some of the key leaders driving this field forward. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.
Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as implanted vagus nerve stimulation systems to treat hypertension, and surface stimulation devices to treat a range of disorders.
Bioelectronic medicine is garnering increased interest from investors and entrepreneurs as it moves into its next phase of growth. Advances in technology and clinical research are widening the range of conditions these therapies can address, creating new commercial opportunities and improving health outcomes for patients. The forum offers a look at where the market stands, where it's going, who's buying, who's selling, and who is up and coming, allowing you to better plan for the next 12 months and beyond.
Several sponsorship opportunities are available for the 2027 Bioelectronic Medicine Forum, taking place April 13, 2027. Each year, the Forum brings together executives from start-up and established bioelectronic medicine firms, VC and investment professionals, and clinical and research leaders focused on commercialization. Topics include the investment climate and returns following recent high-profile exits, how novel diagnostics and biological signals now drive new therapies, advances in the selectivity of bioelectronic therapies, and emerging market segments.
